American Society Of Gene & Cell Therapy company information, Employees & Contact Information

Press Release Service: Capsida to Present Progress Updates at the ASGCT Annual Meeting, Including NHP GLP Toxicology Study Results for its Potential First-in-Class STXBP1 Developmental and Epileptic Encephalopathy Program (CAP-002 STXBP1-DEE CRISPR Medicine News

How to democratize cell and gene therapy: A global approach ScienceDirect.com

Factor Bioscience to Present Non-Viral Gene Editing and Cell Engineering Innovations at the ASGCT Annual Meeting PR Newswire

PackGene to Showcase Scalable AAV Manufacturing, AI-Driven Capsid Engineering, and End-to-End CDMO Solutions at ASGCT 2025 Yahoo Finance

Phase Ib Gene Editing Trials Market Size, Report by 2034 Precedence Research

Acuitas Therapeutics to Present Oral Session and Posters on LNPs at ASGCT 2025 BioPharm International

JCR Pharmaceuticals Presents Preclinical Gene Therapy Data that Demonstrate Promising CNS Uptake at American Society of Gene and Cell Therapy 28th Annual Meeting Business Wire

Coave Therapeutics Launches coAAV-CSF-01, a Novel GlobeNewswire

Pioneering Breakthrough: First Patient Treated with Personalized CRISPR Bioengineer.org

Capsida Presents New GLP Toxicology Data Supporting Recent FDA IND Clearance of Its First-in-Class, IV-administered Gene Therapy for STXBP1 Developmental and Epileptic Encephalopathy CRISPR Medicine News

Top 100 Global Biotechnology Companies Revolutionizing Science and Health ts2.tech

Editorial: Gene therapy 2.0: Biotechnology for circuit engineering and complex therapeutic approaches Frontiers

What Are GTTs? These Technologies Can Impact How a Gene Functions Novartis

A practical approach for adoption of a hub and spoke model for cell and gene therapies in low- and middle-income countries: framework and case studies Nature

New Frontiers in Genomic Medicine at Sanofi Sanofi

Penn Medicine at the American Society of Gene and Cell Therapy 27th Annual Meeting Penn Medicine

Forecasting the potential impact of cell and gene therapies in France: projecting product launches and patients treated Frontiers

CRISPR Therapeutics to Present at the American Society of Gene & Cell Therapy (ASGCT) 2024 Annual Meeting Yahoo Finance

Research Shared at American Society of Gene and Cell Therapy Meeting Seattle Children's

Medicaid coverage practices for approved gene and cell therapies: Existing barriers and proposed policy solutions ScienceDirect.com

CellFE Announces May 2024 Conference Presentations PR Newswire

Gene therapy then and now: A look back at changes in the field over the past 25 years ScienceDirect.com

Gene therapy: The future made present for addressing rare diseases statnews.com

How could gene therapy change healthcare in the next ten years? McKinsey & Company

Exploring Strategies for Developing Robust AAV Platforms BioProcess International

Updates on gene therapy for ‘bubble boy’ disease and cellular immunotherapy at ASGCT St. Jude Children's Research Hospital

Affinia Therapeutics to Present New Data on its AFTX-201 Program in BAG3 Dilated Cardiomyopathy, BBB-Penetrant AAV Capsids, and Proprietary Manufacturing Technology at the 28th Annual American Society of Gene & Cell Therapy 2025 Annual Meeting Business Wire

Evaluating the state of the science for adeno-associated virus integration: An integrated perspective ScienceDirect.com

Vyriad Announces Oral Presentation at the 27th American Society of Gene & Cell Therapy Annual Meeting PR Newswire

Global regulatory progress in delivering on the promise of gene therapies for unmet medical needs ScienceDirect.com

Sharif Tabebordbar, PhD, on Improving In Vivo Gene Editing for DMD CGTLive®

Hirsch Among Outstanding New Investigators at ASGCT 2022 Annual Meeting UNC Health

Vesigen to Present New Preclinical Data on Engineered ARMMs Technology at 2024 ASGCT Annual Meeting Business Wire

Kate Therapeutics Unveils Platform and Pipeline Progress at American Society of Gene & Cell Therapy 2024 Annual Meeting PR Newswire

Novel Gene Therapy for Heart Failure Shows Initial Promise of Efficacy, Safety at 12 Months CGTLive®

Enabling Science at Scale Fierce Pharma

Cell Encapsulation Technology Market Size, Report by 2034 Precedence Research

Dr. Hans-Peter Kiem elected vice president of American Society of Gene & Cell Therapy Fred Hutchinson Cancer Center

Solid Biosciences Highlights Expertise in AAV Gene Therapy with Multiple Abstracts to be Presented at the American Society of Gene & Cell Therapy 24th Annual Meeting Yahoo Finance

HIC Demonstrates Promising Separation of Deaminated and Non-Deaminated AAV Capsids (ASGCT 2024) BioPharm International

Phase-Appropriate cGMP Considerations for Cell and Gene Therapy Contract Pharma

VectorMOD: Method for Bottom-Up Proteomic Characterization of rAAV Capsid Post-Translational Modifications and Vector Impurities Frontiers

Cell Press selected to publish Molecular Therapy family of journals EurekAlert!

Encoded Therapeutics, Inc. Announces $104 Million Series C Financing to Advance Lead Gene Therapy Program in Dravet Syndrome and Unveils its Precision Gene Therapy Platform PR Newswire

June 2025 Science Breakthroughs and Projects: Medicine, Space, Climate, AI & More ts2.tech